Ghana to build two pharmaceutical hubs in Eastern and Central Regions under US$1bn compact

Ghana to build two pharmaceutical hubs in Eastern and Central Regions under US$1bn compact

Ghana will establish two pharmaceutical and biomanufacturing hubs in the Eastern and Central Regions from 2027, under a US$1 billion compact aimed at cutting the country's heavy dependence on imported medicines and turning it into a manufacturing base for West Africa.

The hubs, designated special economic zones, will provide industrial infrastructure for local and international drug makers, with opportunities in contract manufacturing, research and development, and the production of medicines and other health products.

A state-owned special purpose vehicle is expected to begin construction in 2027, according to the 2027 Budget Statement, which names the two regions as locations.

Dr Bernice Makafui Brempong, Presidential Coordinator of the Ghana Pharmaceutical Hub, told the 2026 National Pharmacy Heads' Retreat in Accra that the zones would anchor a transformation of the sector.

"We are in the golden era of the pharmaceutical industry," she said, adding that President John Dramani Mahama is committed to the agenda.

She estimated that Ghana spends about GH¢5 billion a year on pharmaceutical products from India and China, and argued that expanding domestic manufacturing would keep a significant share of that spending at home. "This will create jobs for our people and foreign exchange for the country," she said.

The initiative, part of the government's US$1 billion Pharmaceutical and Biomanufacturing Compact under its New Economy programme, targets raising the share of essential medicines produced locally to between 60 and 80 per cent by 2030, while building capacity to supply other African markets. The hubs will support the production of medicines and vaccines, strengthen local supply chains and create room for technology transfer and skills development.

Dr Brempong linked the push to new demand generated by the Free Primary Healthcare initiative, the Ghana Medical Trust Fund, Mahama Cares, a strengthened National Health Insurance Scheme and 24-Hour Health Services, saying the systems and workforce behind them must be reinforced. The Hub, approved as a Presidential National Legacy Flagship Initiative, is designed to organise the market, secure demand, finance capacity, manufacture medicines and supply Ghana, West Africa and the wider continent. She said protecting the jobs and livelihoods of medicine importers, distributors and their employees is central to the effort.

Dr Martha Gyansa-Lutterodt, Chairperson for the occasion, said a reliable pharmaceutical supply system is essential to the success of the government's healthcare reforms. Free primary healthcare, she argued, can only deliver on its promise if patients consistently get the medicines they need, use them safely and complete treatment without interruption. Free care, she said, should not mean out of stock, and achieving that requires a competent pharmaceutical workforce and systems built around reliable, safe and patient-centred care.

K
Kofi Mensah Staff Journalist

Senior Political & Parliamentary Correspondent for Ghanamma. Covers governance, constitutional law, and national elections in Accra.

Ghanamma Editorial Standards: This report has been prepared and verified in accordance with Ghanamma.com's editorial code of ethics. Factual inquiries, right of reply, or corrections may be submitted directly to our newsroom at info@ghanamma.com. 📰 Syndicated wire assistance & reporting credit: Daily Graphic.
Share: WhatsApp WhatsApp
💬

Comments (0)

Join the Conversation

No comments yet. Be the first to share your opinion!

You may like